LOW FAT OR A LOW CARBOHYDRATE DIETARY AND BREAST CANCER RISK

低脂肪或低碳水化合物饮食与乳腺癌风险

基本信息

  • 批准号:
    7625448
  • 负责人:
  • 金额:
    $ 39.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-23 至 2007-11-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Obesity is linked to the risk of breast and many other cancers as well as cardiovascular disease, diabetes, musculoskeletal disorders, and reduced life expectancy. Establishing effective behaviors regarding diet and exercise are the foundations of weight control. The most effective dietary pattern for cancer prevention or weight loss is a controversial topic and the subject of great debate among various facets of the scientific community. Low carbohydrate diets such as the Atkins Diet, the Scarsdale Diet and the Zone Diet advocate a diet consisting of between 10% and 30% of total calories from carbohydrates and approximately 40% of total calories from protein. This amount of protein is exceeds the National Academy of Sciences recommended range of between 10 and 35% of total calories from protein (Food and Nutrition Board, 2002). Proponents of low carbohydrate diets report that diets high in carbohydrates result in higher plasma insulin levels and promote lipogenesis. Low carbohydrate diets have been extraordinarily popular among the general public and some short-term studies report greater loss of body fat and greater maintenance of lean body mass when compared with a diet rich in carbohydrate but low in fat (Farnsworth, 2003; Foster, 2003). However, there are only a few studies of reduced carbohydrate diets that are greater than six months in duration and long-term weight maintenance and safety are unknown. Furthermore, the published studies have not utilized intense education, feedback, and monitoring which are likely to be key determinants of success. Thus, we propose an 18-month clinical trial in premenopausal women with intensive combined nutrition and physical activity counseling to examine the efficacy in inducing and maintaining weight loss. This randomized phase II pilot trial will provide intensively monitored intervention to all participants, and will compare a low-fat dietary intervention to a protein-sparing (low carbohydrate) intervention. We hypothesize that calorie-restriction/calorie expenditure is the major determinant of successful weight loss and that macronutrient distribution is less important with no significant long-term difference between diets. Adherence to each diet and physical activity recommendations are key outcomes. These data will provide essential feasibility data for a future larger, multi-institutional, randomized study of weight control, physical activity and cancer risk factors. Secondary goals of the study include a number of anthropometric and biological measures that may be related to cancer risk.
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 肥胖与乳腺癌和许多其他癌症的风险以及心血管疾病、糖尿病、肌肉骨骼疾病和预期寿命缩短有关。建立有效的饮食和锻炼行为是控制体重的基础。 预防癌症或减肥最有效的饮食模式是一个有争议的话题,也是科学界各方面激烈辩论的主题。低碳水化合物饮食,如阿特金斯饮食、斯卡斯代尔饮食和区域饮食,提倡总卡路里的10%到30%来自碳水化合物,大约40%的总卡路里来自蛋白质。这个蛋白质含量超过了美国国家科学院推荐的蛋白质总卡路里的10%到35%的范围(食品和营养委员会,2002)。低碳水化合物饮食的支持者报告说,高碳水化合物饮食会导致较高的血浆胰岛素水平,并促进脂肪生成。低碳水化合物饮食在公众中非常受欢迎,一些短期研究报告称,与富含碳水化合物但脂肪含量低的饮食相比,更多的体脂损失和更好的瘦体重保持(Farnsworth,2003;Foster,2003)。然而,只有几项关于持续时间超过六个月的减少碳水化合物饮食的研究,而且长期体重维持和安全性尚不清楚。此外,已发表的研究没有利用密集的教育、反馈和监测,而这些可能是成功的关键决定因素。 因此,我们建议在绝经前妇女中进行一项为期18个月的临床试验,通过强化营养和体力活动咨询来检验其诱导和维持体重减轻的效果。这项随机的第二阶段试点试验将为所有参与者提供密集监测的干预措施,并将低脂肪饮食干预与节省蛋白质(低碳水化合物)干预进行比较。我们假设,卡路里限制/卡路里消耗是成功减肥的主要决定因素,而大量营养素的分配不那么重要,不同饮食之间没有显着的长期差异。坚持每一种饮食和体力活动建议是关键的结果。这些数据将为未来一项关于体重控制、体力活动和癌症风险因素的更大规模、多机构、随机研究提供必要的可行性数据。这项研究的次要目标包括一些可能与癌症风险相关的人体测量和生物学测量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ELECTRA D. PASKETT其他文献

ELECTRA D. PASKETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ELECTRA D. PASKETT', 18)}}的其他基金

Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10381633
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:
Project 2: Testing Multi-Level Interventions to Improve HPV Vaccination
项目 2:测试多层次干预措施以改善 HPV 疫苗接种
  • 批准号:
    10381631
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10495879
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10268467
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:
Project 2: Testing Multi-Level Interventions to Improve HPV Vaccination
项目 2:测试多层次干预措施以改善 HPV 疫苗接种
  • 批准号:
    10627804
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:
Core 1: Intervention and Consortium (ICC)
核心 1:干预与联盟 (ICC)
  • 批准号:
    10268468
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:
Core 1: Intervention and Consortium (ICC)
核心 1:干预与联盟 (ICC)
  • 批准号:
    10381634
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10701200
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:
Core 1: Intervention and Consortium (ICC)
核心 1:干预与联盟 (ICC)
  • 批准号:
    10268456
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:
Core 1: Intervention and Consortium (ICC)
核心 1:干预与联盟 (ICC)
  • 批准号:
    10627826
  • 财政年份:
    2019
  • 资助金额:
    $ 39.82万
  • 项目类别:

相似海外基金

Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
  • 批准号:
    10760051
  • 财政年份:
    2023
  • 资助金额:
    $ 39.82万
  • 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
  • 批准号:
    2303692
  • 财政年份:
    2023
  • 资助金额:
    $ 39.82万
  • 项目类别:
    Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
  • 批准号:
    468168
  • 财政年份:
    2022
  • 资助金额:
    $ 39.82万
  • 项目类别:
    Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10427960
  • 财政年份:
    2022
  • 资助金额:
    $ 39.82万
  • 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
  • 批准号:
    10577074
  • 财政年份:
    2022
  • 资助金额:
    $ 39.82万
  • 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
  • 批准号:
    486588
  • 财政年份:
    2022
  • 资助金额:
    $ 39.82万
  • 项目类别:
    Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
  • 批准号:
    2760091
  • 财政年份:
    2022
  • 资助金额:
    $ 39.82万
  • 项目类别:
    Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
  • 批准号:
    10621188
  • 财政年份:
    2022
  • 资助金额:
    $ 39.82万
  • 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
  • 批准号:
    10891016
  • 财政年份:
    2021
  • 资助金额:
    $ 39.82万
  • 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
  • 批准号:
    10230365
  • 财政年份:
    2020
  • 资助金额:
    $ 39.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了